TNF and neoplasm: The recent studies demonstrated that the higher number of tumor islets with infiltration of TNFα+ TAMs (cytotoxic M1 phenotype) confers a survival advantage in non-small-cell lung cancer (NSCLC) and other malignancies (14, 65).